These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 33374546)
1. Bisphosphonates Reduce Smoking-Induced Osteoporotic-Like Alterations by Regulating RANKL/OPG in an Osteoblast and Osteoclast Co-Culture Model. Zhu S; Häussling V; Aspera-Werz RH; Chen T; Braun B; Weng W; Histing T; Nussler AK Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374546 [TBL] [Abstract][Full Text] [Related]
2. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin. Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296 [TBL] [Abstract][Full Text] [Related]
3. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse. Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637 [TBL] [Abstract][Full Text] [Related]
4. Influence of bisphosphonates on the osteoblast RANKL and OPG gene expression in vitro. Koch FP; Merkel C; Ziebart T; Smeets R; Walter C; Al-Nawas B Clin Oral Investig; 2012 Feb; 16(1):79-86. PubMed ID: 20938793 [TBL] [Abstract][Full Text] [Related]
5. Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway. Luo XH; Guo LJ; Xie H; Yuan LQ; Wu XP; Zhou HD; Liao EY J Bone Miner Res; 2006 Oct; 21(10):1648-56. PubMed ID: 16995820 [TBL] [Abstract][Full Text] [Related]
6. Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity. Irie A; Takami M; Kubo H; Sekino-Suzuki N; Kasahara K; Sanai Y Bone; 2007 Aug; 41(2):165-74. PubMed ID: 17560185 [TBL] [Abstract][Full Text] [Related]
8. [Effect of Erigeron Breviscapus on the expression of OPG/RANKL/RANK in osteoblasts and pre-osteoclasts in vitro]. Liu CG; Luo QX; Ling TY; Mo YY; Cheng ZL; Huang SG; Mo H Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Dec; 33(12):1658-64. PubMed ID: 24517065 [TBL] [Abstract][Full Text] [Related]
9. [Establish mouse osteoblast -osteoclast cell co-culture system in a Transwell chamber]. Mo GY; Zhang SC; Li YX; Guo HZ; Guo DQ; Li DX; Tang YC; Mo L; Luo PJ; Ma YH Zhongguo Gu Shang; 2018 Mar; 31(3):241-247. PubMed ID: 29600675 [TBL] [Abstract][Full Text] [Related]
10. Avenanthramides Prevent Osteoblast and Osteocyte Apoptosis and Induce Osteoclast Apoptosis in Vitro in an Nrf2-Independent Manner. Pellegrini GG; Morales CC; Wallace TC; Plotkin LI; Bellido T Nutrients; 2016 Jul; 8(7):. PubMed ID: 27409635 [TBL] [Abstract][Full Text] [Related]
11. The Proteasome Inhibitor Carfilzomib Suppresses Parathyroid Hormone-induced Osteoclastogenesis through a RANKL-mediated Signaling Pathway. Yang Y; Blair HC; Shapiro IM; Wang B J Biol Chem; 2015 Jul; 290(27):16918-28. PubMed ID: 25979341 [TBL] [Abstract][Full Text] [Related]
12. The effect of the alendronate on OPG/RANKL system in differentiated primary human osteoblasts. Enjuanes A; Ruiz-Gaspà S; Peris P; Ozalla D; Álvarez L; Combalia A; Martínez de Osaba MJ; Monegal A; Pares A; Guañabens N Endocrine; 2010 Feb; 37(1):180-6. PubMed ID: 20963568 [TBL] [Abstract][Full Text] [Related]
13. IL-3 Differentially Regulates Membrane and Soluble RANKL in Osteoblasts through Metalloproteases and the JAK2/STAT5 Pathway and Improves the RANKL/OPG Ratio in Adult Mice. Singh K; Piprode V; Mhaske ST; Barhanpurkar-Naik A; Wani MR J Immunol; 2018 Jan; 200(2):595-606. PubMed ID: 29203513 [TBL] [Abstract][Full Text] [Related]
14. Antiresorptive activity of osteoprotegerin requires an intact heparan sulfate-binding site. Li M; Xu D Proc Natl Acad Sci U S A; 2020 Jul; 117(29):17187-17194. PubMed ID: 32636266 [TBL] [Abstract][Full Text] [Related]
15. Elevated Gα11 expression in osteoblast lineage cells promotes osteoclastogenesis and leads to enhanced trabecular bone accrual in response to pamidronate. Dela Cruz A; Grynpas MD; Mitchell J Am J Physiol Endocrinol Metab; 2016 May; 310(10):E811-20. PubMed ID: 27006198 [TBL] [Abstract][Full Text] [Related]
16. Silicate modulates the cross-talk between osteoblasts (SaOS-2) and osteoclasts (RAW 264.7 cells): inhibition of osteoclast growth and differentiation. Schröder HC; Wang XH; Wiens M; Diehl-Seifert B; Kropf K; Schloßmacher U; Müller WE J Cell Biochem; 2012 Oct; 113(10):3197-206. PubMed ID: 22615001 [TBL] [Abstract][Full Text] [Related]
17. Cocultures of osteoblasts and osteoclasts are influenced by local application of zoledronic acid incorporated in a poly(D,L-lactide) implant coating. Greiner S; Kadow-Romacker A; Schmidmaier G; Wildemann B J Biomed Mater Res A; 2009 Oct; 91(1):288-95. PubMed ID: 18980195 [TBL] [Abstract][Full Text] [Related]
18. Effects of photobiomodulation on bone remodeling in an osteoblast-osteoclast co-culture system. Hong JU; Kwon JJ; Heo SC; Shin SH; Kim HJ; Lee JY Lasers Med Sci; 2022 Mar; 37(2):1049-1059. PubMed ID: 34142255 [TBL] [Abstract][Full Text] [Related]
19. Zebrafish scales respond differently to in vitro dynamic and static acceleration: analysis of interaction between osteoblasts and osteoclasts. Kitamura K; Takahira K; Inari M; Satoh Y; Hayakawa K; Tabuchi Y; Ogai K; Nishiuchi T; Kondo T; Mikuni-Takagaki Y; Chen W; Hattori A; Suzuki N Comp Biochem Physiol A Mol Integr Physiol; 2013 Sep; 166(1):74-80. PubMed ID: 23632157 [TBL] [Abstract][Full Text] [Related]
20. Bisphosphonates modulate the expression of OPG and M-CSF in hMSC-derived osteoblasts. Ohe JY; Kwon YD; Lee HW Clin Oral Investig; 2012 Aug; 16(4):1153-9. PubMed ID: 21938481 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]